beta
Text
1. The defendant's appeal is dismissed.
2. The costs of appeal shall be borne by the Defendant.
Purport of claim and appeal
1..
Reasons
1. Basic facts
A. On November 16, 2009, the Plaintiff entered into an insurance contract between the Defendant and the Defendant for the non-distribution of dividends and the trop VIP insurance (Hi0911), which is the Defendant’s insurance product, (hereinafter “instant insurance”) and entered into a stroke stroke stroke stroke stroke stroke stroke stroke (hereinafter “instant special agreement”). The contents of the said special agreement are as listed below.
[23. The term "special terms and conditions" of Article 1. (1) of the Special Terms and Conditions for the Guarantee of Brain Medical Benefits) ① The Company will pay the following amount to the beneficiary as a stroke amount only once for the first time in accordance with this Special Terms and Conditions in the event that the insured (the insured) becomes final and conclusive during the insurance period of this Special Terms and Conditions (the "Special Terms and Conditions" and "the insurance period of this Special Terms and Conditions" are "the insurance period" and "the insurance period of this Special Terms and Conditions") of this Special Terms and Conditions, only once for the first time in accordance with this Special Terms and Conditions:
The amount equivalent to 100% of the purchase amount of the insurance under this special contract entered into in the insurance policy (certificate of insurance) for at least one year from the date of the contract, which is less than one year from the date of the contract of the former amount of the gold contract.
(A) 6. (A) The term “stroke” in paragraph (1) means a disease (see attached Table 12) classified as brain stroke in the category of the fifth Korean Standard Disease Classification.
(7) The diagnosis and confirmation of "cerebral stroke" shall be made by a hospital, a medical member, or a medical doctor (excluding a dentist) of a medical institution recognized by the company as equivalent to the hospital under Article 3 (2) of the Medical Service Act, and such diagnosis shall be conducted together with a pathological examination.